Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.546 USD | +9.44% | +9.28% | -50.47% |
May. 15 | Sector Update: Health Care Stocks Advance in Afternoon Trading | MT |
May. 15 | CASI Pharmaceuticals Gets FDA Clearance For Blood Disorder Study | MT |
Financials (USD)
Sales 2024 * | 19.8M | Sales 2025 * | 46.48M | Capitalization | 46.06M |
---|---|---|---|---|---|
Net income 2024 * | -35M | Net income 2025 * | -33M | EV / Sales 2024 * | 2.33 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.99 x |
P/E ratio 2024 * |
-1.39
x | P/E ratio 2025 * |
-1.66
x | Employees | 176 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.99% |
1 day | +9.44% | ||
1 week | +9.28% | ||
Current month | +50.64% | ||
1 month | +41.27% | ||
3 months | -36.11% | ||
6 months | -36.68% | ||
Current year | -50.47% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Wu He
CEO | Chief Executive Officer | 59 | 19-04-01 |
Wei Zhang
DFI | Director of Finance/CFO | 64 | 18-08-31 |
Chun Hua Wang
COO | Chief Operating Officer | 52 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Wu He
CEO | Chief Executive Officer | 59 | 19-04-01 |
Yue Wu
BRD | Director/Board Member | 62 | 13-03-31 |
Zhen Bo Su
BRD | Director/Board Member | 48 | 23-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 3.546 | +9.44% | 37,491 |
24-05-23 | 3.24 | -6.36% | 8,713 |
24-05-22 | 3.46 | +11.97% | 34,475 |
24-05-21 | 3.09 | -1.28% | 15,033 |
24-05-20 | 3.13 | -5.15% | 14,889 |
Delayed Quote Nasdaq, May 24, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.47% | 42.09M | |
+38.51% | 728B | |
+33.05% | 603B | |
-6.23% | 360B | |
+18.78% | 332B | |
+1.35% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.19% | 164B |
- Stock Market
- Equities
- CASI Stock